ULURU Inc

(PINK:ULUR)

Latest On ULURU Inc (ULUR):

Date/Time Type Description Signal Details
2020-12-04 06:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:50 ESTFinancialsCompany financials have been released.Neutral
2020-10-08 21:11 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:28 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:40 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:20 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:46 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 16:28 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:45 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 04:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 20:45 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 08:33 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 00:51 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 16:07 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 21:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 12:37 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 07:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 23:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 20:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 04:07 ESTFinancialsCompany financials have been released.Neutral
2020-06-25 07:29 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 16:06 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 08:17 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 09:51 ESTFinancialsCompany financials have been released.Neutral
2020-06-07 19:51 ESTFinancialsCompany financials have been released.Neutral
2020-06-05 15:38 ESTFinancialsCompany financials have been released.Neutral
2020-06-03 19:29 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 08:56 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 04:42 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 03:57 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 11:40 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 04:00 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 09:20 ESTFinancialsCompany financials have been released.Neutral
2020-05-02 23:47 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 20:05 ESTFinancialsCompany financials have been released.Neutral
2020-04-30 07:34 ESTFinancialsCompany financials have been released.Neutral

About ULURU Inc (ULUR):

ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas.

ULUR Quotes by TradingView

See Advanced Chart

General

  • Name ULURU Inc
  • Symbol ULUR
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 2
  • Last Split Factor10:1
  • Last Split Date2020-03-23
  • Fiscal Year EndDecember
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.uluruinc.info
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 18.11
  • Price/Book (Most Recent Quarter) 2.37
  • Enterprise Value Revenue 18.09
View More

Financials

  • Most Recent Quarter 2018-09-30
  • Operating Margin -322%
  • Return on Assets -14%
  • Return on Equity -41%
  • Revenue 568744
  • Earnings Per Share -$0.01
  • Revenue Per Share $0.03
  • Gross Profit 487465
  • Quarterly Earnings Growth -57.9%
View More

Highlights

  • Market Capitalization 10.29 million
  • EBITDA -1356503
  • Book Value Per Share $0.22
View More

Share Statistics

  • Shares Outstanding 20.13 million
  • Shares Float 6.67 million
  • % Held by Insiders <1%
  • % Held by Institutions 0.25%
  • Shares Short 2034
  • Shares Short Prior Month 2710
  • Short Ratio 0.08
View More

Technicals

  • Beta -2.98
  • 52 Week High $1.1
  • 52 Week Low $0.11
  • 50 Day Moving Average 0.35
  • 200 Day Moving Average 0.52
View More

Dividends

  • Dividend Date 2020-03-23
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ULURU Inc (ULUR) Dividend Calendar:

ULUR's last dividend payment was made to shareholders on March 23, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ULURU Inc (ULUR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2018-09-302018-11-13$84612$-0.00
2018-06-302018-09-30$105550-$0.03
2018-03-312018-06-30$83795-$0.03
2017-12-312018-03-31$294787-$0.03
2017-09-302017-12-31$201000-$0.02
2017-06-302017-09-30$4000-$0.03
2017-03-312017-06-30$217000-$0.07
2016-12-312017-03-31$64000-$0.07$0.00
2016-09-302016-12-31$6000-$0.41
2016-06-302016-09-30$264000-$0.11
2016-03-312016-06-30$109000-$0.09
2015-12-312016-03-31$358000-$0.17
2015-09-302015-12-31$24000-$0.12
2015-06-302015-09-30$259000-$0.35
2015-03-312015-06-30$295000-$0.29
2014-12-312015-03-31$230000-$0.30$0.00
2014-09-302014-12-31$323000$0.13
2014-06-302014-09-30$209000-$0.28
2014-03-312014-06-30$102000-$0.29
2013-12-312014-03-31$129000-$0.41$0.00
2013-09-302013-12-31$111000-$0.48
2013-06-302013-09-30$29000-$0.48
2013-03-312013-06-30$102000-$0.61
2012-12-312013-03-31$166000-$0.57$0.00
2012-09-302012-12-31$89000-$1.03
2012-06-302012-09-30$56000-$1.05
2012-03-312012-06-30$60000-$1.08
2011-12-312012-03-31$256000-$1.07$0.00
2011-09-302011-12-31$73000-$1.28
2011-06-302011-09-30$81000-$1.75
2011-03-312011-06-30$75000-$1.74
2010-12-312011-03-31$1.03 million-$2.00
2010-09-302010-12-31$61000-$0.54
2010-06-302010-08-17$232000-$0.41
2010-03-312010-05-14$235000-$0.24
2009-12-312010-03-24$232000-$0.45
2009-09-302009-11-16$131000-$0.35
2009-06-302009-08-14$136000-$6.00
2009-03-312009-05-15$169000-$7.50
2008-12-312009-03-30$257000-$6.00
2008-09-302008-11-10$125000-$6.00
2008-06-302008-08-11$95000-$0.56
2008-03-312008-05-12$256000-$0.44
2007-09-302007-11-13$130000-$3.00-$1.50-100%
2007-06-302007-08-13$118000-$3.00-$1.50-100%
2007-03-312007-05-30$384000-$0.21

ULURU Inc (ULUR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ULURU Inc (ULUR) Chart:

ULUR chart by TradingView

ULURU Inc (ULUR) News:

Below you will find a list of latest news for ULURU Inc (ULUR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ULURU Inc (ULUR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

ULURU Inc (ULUR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2019-11-25DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1168220/000116822019000001/0001168220-19-000001-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1168220/000114036119002500/0001140361-19-002500-index.htm
2019-03-01S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004248/0001140361-19-004248-index.htm
2019-03-01S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004252/0001140361-19-004252-index.htm
2019-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004253/0001140361-19-004253-index.htm
2019-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004256/0001140361-19-004256-index.htm
2019-03-01S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004257/0001140361-19-004257-index.htm
2019-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004258/0001140361-19-004258-index.htm
2019-03-01S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004260/0001140361-19-004260-index.htm
2019-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004261/0001140361-19-004261-index.htm
2019-03-01S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004262/0001140361-19-004262-index.htm
2019-03-01S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004263/0001140361-19-004263-index.htm
2019-03-01S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004264/0001140361-19-004264-index.htm
2019-03-01S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1168220/000114036119004266/0001140361-19-004266-index.htm
2019-03-0115-12GSecurities registration termination [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1168220/000114036119004267/0001140361-19-004267-index.htm
2017-04-1710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1168220/000116822017000020/0001168220-17-000020-index.htm
2017-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1168220/000116822017000024/0001168220-17-000024-index.htm
2017-06-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1168220/000116822017000028/0001168220-17-000028-index.htm
2017-06-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1168220/000116822017000034/0001168220-17-000034-index.htm
2017-06-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1168220/000116822017000035/0001168220-17-000035-index.htm
2017-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1168220/000116822017000040/0001168220-17-000040-index.htm
2017-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1168220/000116822017000046/0001168220-17-000046-index.htm
2017-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1168220/000116822017000048/0001168220-17-000048-index.htm
2017-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1168220/000116822017000050/0001168220-17-000050-index.htm
2018-03-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1168220/000116822018000004/0001168220-18-000004-index.htm
2018-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1168220/000116822018000008/0001168220-18-000008-index.htm
2018-04-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1168220/000116822018000011/0001168220-18-000011-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1168220/000116822018000014/0001168220-18-000014-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1168220/000116822018000015/0001168220-18-000015-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1168220/000116822018000017/0001168220-18-000017-index.htm
2018-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1168220/000116822018000021/0001168220-18-000021-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1168220/000116822018000025/0001168220-18-000025-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1168220/000116822018000031/0001168220-18-000031-index.htm
2018-12-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1168220/000116822018000033/0001168220-18-000033-index.htm
2019-11-25DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1168220/000116822019000001/0001168220-19-000001-index.htm
2017-04-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1168220/000157104917003560/0001571049-17-003560-index.htm
2017-04-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1168220/000157104917003561/0001571049-17-003561-index.htm
2019-03-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1168220/999999999519000363/9999999995-19-000363-index.htm
2019-03-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1168220/999999999519000364/9999999995-19-000364-index.htm
2019-03-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1168220/999999999519000365/9999999995-19-000365-index.htm
2019-03-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1168220/999999999519000366/9999999995-19-000366-index.htm